V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007629 | 220011690 | 1.66 | 45.2 | Disease modification (D) | 2017-10-01 | 2017-12-05 | AML16 DA 3+10 | N | N | 220032814 | AML16 TRIAL |
| 220007630 | 220003016 | 1.67 | 108 | null | 2017-01-23 | 2017-01-30 | GEMCARBO | N | N | 220032817 | GEMCARBO |
| 220007631 | 220003017 | null | 86 | Disease modification (D) | null | 2013-12-06 | AML16 DA 3+10 | N | null | 220032820 | AML16 TRIAL |
| 220007632 | 220003017 | 1.82 | 74.1 | Palliative (P) | 2017-04-11 | 2017-04-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032820 | CISPLATIN + GEMCITABINE |
| 220007633 | 220003018 | 1.61 | 52 | Palliative (P) | 2013-03-11 | 2013-03-11 | GemCarbo Days 1+8 | 02 | null | 220032825 | GEMCARBO |
| 220007634 | 220003019 | 1.6 | 82.6 | null | 2016-03-21 | 2016-03-22 | CISPLATIN + GEMCITABINE | 02 | N | 220032826 | CISPLATIN + GEMCITABINE |
| 220007635 | 220003020 | 1.76 | 0 | null | 2017-07-29 | 2017-08-11 | CISPLATIN + GEMCITABINE | 2 | N | 220032827 | CISPLATIN + GEMCITABINE |
| 220007636 | 220003021 | null | 76.8 | null | null | 2014-08-23 | IDARUBICIN + TRETINOIN | null | N | 220032828 | IDARUBICIN + TRETINOIN |
| 220007637 | 220011692 | null | 92.1 | Disease modification (D) | 2013-10-25 | 2013-10-28 | AML 18 TRIAL | 01 | N | 220032832 | AML18 TRIAL |
| 220007638 | 220011692 | 1.85 | 88.8 | null | 2015-01-07 | 2015-01-11 | AML 18 TRIAL | Y | N | 220032832 | AML18 TRIAL |
| 220007639 | 220003022 | null | 47.2 | Palliative (P) | 2013-10-23 | 2013-10-23 | AML16 DA 3+10 | 02 | N | 220032836 | AML16 TRIAL |
| 220007640 | 220003023 | 1.79 | 73.9 | Palliative (P) | 2017-11-26 | 2017-12-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032838 | CARBOPLATIN + PACLITAXEL |
| 220007641 | 220003023 | 1.7 | null | Curative (C) | 2015-07-13 | 2015-07-19 | AML16 DA 3+10 | null | N | 220032838 | AML16 TRIAL |
| 220007642 | 220003023 | 1.65 | null | Palliative (P) | 2016-03-31 | 2016-04-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032838 | CISPLATIN + GEMCITABINE |
| 220007643 | 220003023 | 1.83 | 71 | Curative (C) | 2013-03-02 | 2013-03-02 | AML 18 TRIAL | Y | null | 220032838 | AML18 TRIAL |
| 220007644 | 220003023 | 1.62 | 81.7 | null | null | 2015-07-13 | AML16 DA 3+10 | N | Y | 220032838 | AML16 TRIAL |
| 220007645 | 220003023 | 0 | 125 | Palliative (P) | 2015-05-31 | 2015-07-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032838 | CARBOPLATIN + PACLITAXEL |
| 220007646 | 220003024 | 1.87 | 88 | Curative (C) | 2013-02-09 | 2013-02-14 | AML16 DA 3+10 | 02 | N | 220032846 | AML16 TRIAL |
| 220007647 | 220003024 | 1.59 | 47.5 | Palliative (P) | null | 2015-05-15 | Carboplatin + Paclitaxel (weekly) | 02 | null | 220032846 | CARBOPLATIN + PACLITAXEL |
| 220007648 | 220003024 | 1.63 | 89 | Palliative (P) | 2016-03-21 | 2016-03-29 | GEMCARBO | N | N | 220032846 | GEMCARBO |
| 220007649 | 220003024 | 1.77 | 73.5 | Disease modification (D) | 2013-01-31 | 2013-01-31 | AML18 PILOT TRIAL | 1 | N | 220032846 | PILOT TRIAL |
| 220007650 | 220003025 | null | null | Curative (C) | 2015-05-08 | 2015-05-09 | IDARUBICIN + TRETINOIN | N | N | 220032856 | IDARUBICIN + TRETINOIN |
| 220007651 | 220003026 | 1.65 | 88.5 | null | 2016-09-08 | 2016-09-09 | CISPLATIN + GEMCITABINE | 02 | N | 220032859 | CISPLATIN + GEMCITABINE |
| 220007652 | 220003027 | 0 | 72.5 | null | null | 2016-04-21 | AML16 DA 3+10 | N | N | 220032862 | AML16 TRIAL |
| 220007653 | 220003028 | 1.79 | 70.3 | Curative (C) | 2016-06-24 | 2016-06-24 | AML 18 TRIAL | N | null | 220032863 | AML18 TRIAL |
| 220007654 | 220003029 | 0 | 61 | Neo-adjuvant (N) | 2015-10-16 | 2015-10-26 | Dasatinib | N | N | 220032865 | DASATINIB |
| 220007655 | 220003029 | null | null | Curative (C) | null | 2014-04-05 | AML 18 TRIAL | 1 | N | 220032865 | AML18 TRIAL |
| 220007656 | 220003030 | 1.83 | 139.7 | Palliative (P) | 2015-03-25 | 2015-03-26 | Dasatinib | 2 | N | 220032870 | DASATINIB |
| 220007657 | 220003031 | 1.71 | null | Curative (C) | 2017-04-02 | 2017-04-03 | AML 18 TRIAL | Y | N | 220032871 | AML18 TRIAL |
| 220007658 | 220003031 | null | null | Disease modification (D) | 2017-06-27 | 2017-06-28 | AML 18 TRIAL | N | null | 220032871 | AML18 TRIAL |
| 220007659 | 220003031 | 1.67 | 96.4 | Curative (C) | 2014-05-20 | 2014-05-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032871 | CARBOPLATIN + PACLITAXEL |
| 220007663 | 220003033 | 1.75 | 86 | Curative (C) | null | 2014-06-20 | AML 18 Pilot Trial | N | null | 220032881 | PILOT TRIAL |
| 220007664 | 220003034 | 1.61 | 71 | Curative (C) | 2017-05-01 | 2017-05-03 | IDARUBICIN + TRETINOIN | N | N | 220032882 | IDARUBICIN + TRETINOIN |
| 220007665 | 220003034 | 1.7 | 48.9 | Palliative (P) | 2014-12-21 | 2015-01-05 | CARBOPLATIN + GEMCITABINE | 02 | N | 220032882 | GEMCARBO |
| 220007666 | 220003034 | 1.72 | 80 | Curative (C) | 2017-04-04 | 2017-04-04 | AML 18 TRIAL | N | N | 220032882 | AML18 TRIAL |
| 220007667 | 220003035 | 1.8 | 76.9 | Curative (C) | null | 2013-02-02 | AML16 Low Dose Cytarabine | 02 | N | 220032887 | AML16 TRIAL |
| 220007670 | 220003037 | 1.49 | 86.3 | null | 2015-07-03 | 2015-07-03 | IDARUBICIN + TRETINOIN | N | N | 220032893 | IDARUBICIN + TRETINOIN |
| 220007671 | 220003038 | 1.85 | 87.5 | Curative (C) | 2016-11-21 | 2016-11-21 | AML 18 TRIAL | Y | N | 220032898 | AML18 TRIAL |
| 220007672 | 220003038 | 1.6 | 85.7 | null | 2017-02-23 | 2017-02-23 | AML16 DA 3+10 | 02 | N | 220032898 | AML16 TRIAL |
| 220007673 | 220003038 | 1.84 | 84.6 | Curative (C) | 2016-10-04 | 2016-10-04 | AML 18 TRIAL | 1 | N | 220032898 | AML18 TRIAL |
| 220007674 | 220003038 | 1.75 | null | Palliative (P) | 2014-11-19 | 2014-11-19 | GemCarbo Days 1+8 | N | N | 220032898 | GEMCARBO |
| 220007675 | 220020435 | 1.8 | null | Curative (C) | 2017-09-20 | 2017-09-21 | AML 18 TRIAL | Y | N | 220032905 | AML18 TRIAL |
| 220007676 | 220003039 | 1.61 | null | Curative (C) | 2017-11-07 | 2017-11-08 | Dasatinib | 02 | N | 220032908 | DASATINIB |
| 220007677 | 220003040 | 1.6 | 87.6 | Palliative (P) | 2014-04-06 | 2014-04-15 | GEMCARBO | N | null | 220032909 | GEMCARBO |
| 220007678 | 220003041 | 1.61 | 0 | Not known (9) | 2015-06-15 | 2015-06-15 | IDARUBICIN + TRETINOIN | N | null | 220032911 | IDARUBICIN + TRETINOIN |
| 220007679 | 220003042 | 1.6 | null | Palliative (P) | 2013-07-02 | 2013-07-17 | GemCarbo Days 1+8 | N | null | 220032915 | GEMCARBO |
| 220007682 | 220003043 | 1.61 | 45.2 | Palliative (P) | 2014-06-23 | 2014-08-03 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 220032918 | CISPLATIN + GEMCITABINE |
| 220007683 | 220003043 | 1.76 | 0 | Curative (C) | 2014-09-13 | 2014-09-13 | AML18 PILOT TRIAL | null | Y | 220032918 | PILOT TRIAL |
| 220007684 | 220003044 | 1.82 | 73 | Curative (C) | 2015-01-06 | 2015-01-06 | CARBOPLATIN + PACLITAXEL | 02 | null | 220032920 | CARBOPLATIN + PACLITAXEL |
| 220007685 | 220003044 | 1.57 | 67.3 | Curative (C) | 2014-11-10 | 2014-11-18 | CARBOPLATIN + PACLITAXEL | 02 | N | 220032920 | CARBOPLATIN + PACLITAXEL |